Vaccine-preventable diseases

Latest updates

Data

Download today’s data on the geographic distribution of COVID-19 cases worldwide

Table -

Data

Poster: COVID-19 - Plan your journey

Poster -

Publication

Third external quality assessment on antimicrobial susceptibility testing and detection of ESBL-, acquired AmpC-, and carbapenemase-production of Salmonella, 2017

External quality assessment -

Publication

Communicable disease threats report, 24-30 May 2020, week 22

Publication -

Publication

Third external quality assessment on antimicrobial susceptibility testing and detection of ESBL-, acquired AmpC-, and carbapenemase-production of Salmonella, 2017

External quality assessment -

Publication

Communicable disease threats report, 24-30 May 2020, week 22

Publication -

Publication

Methodology for estimating point prevalence of SARS-CoV-2 infection by pooled RT-PCR testing

Technical report -

Publication

Considerations for travel-related measures to reduce spread of COVID-19 in the EU/EEA

Technical report -

News

ECDC marks 15 year anniversary

News story -

News

ECDC launches new weekly COVID-19 surveillance report

Epidemiological update -

News

ECDC publishes first report monitoring progress towards the elimination of hepatitis B and C in the EU/EEA

News story -

News

Measles continues to spread across the EU/EEA – No time for complacency

News story -

Event

European Scientific Conference on Applied Infectious Disease Epidemiology 2018

21 Nov 2018 - 23 Nov 2018
Saint Julian's, Malta

Event

ESCAIDE 2020: Call for abstracts now open

1 Jun 2020 - 14 Sep 2020

Event

Spring European Testing Week 2020

15 May 2020 - 22 May 2020

Event

SAVE LIVES: Clean Your Hands – ECDC supports World Hand Hygiene Day 2020

5 May 2020

Data

Download today’s data on the geographic distribution of COVID-19 cases worldwide

Table -

Data

Poster: COVID-19 - Plan your journey

Poster -

Data

Number of rubella cases by country, EU/EEA and the UK, March 2020

Map -

Data

Rubella notification rate per million population by country, EU/EEA and the UK, 1 April 2019–31 March 2020

Map -

Vaccine-preventable diseases

2009 influenza A (H1N1) pandemic

The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza.

Cholera

Cholera is an acute diarrhoeal infection caused by the bacterium Vibrio cholera of serogroups O1 or O139. Humans are the only relevant reservoir, even though Vibrios can survive for a long time in coastal waters contaminated by human excreta.

Congenital rubella syndrome (CRS)

Congenital rubella is the infection of a foetus with rubella virus following the infection of the mother during pregnancy. ‘Congenital’ indicates that the foetus also becomes infected during pregnancy.

Diphtheria

Diphtheria is a disease caused by bacteria Corynebacterium diphtheriae and Corynebacterium ulcerans. It can cause respiratory symptoms or non-respiratory forms that affect other parts of the body, including the skin.

Hepatitis B

Hepatitis B is a liver disease that results from infection with the hepatitis B virus (HBV) and is spread through contact with infected body fluids or blood products.

Human papillomavirus

Cervical cancer is the second most common cancer after breast cancer to affect women aged 15–44 years in the European Union. Each year, there are around 33 000 cases of cervical cancer in the EU, and 15 000 deaths. The primary cause of cervical cancer is a persistent infection of the genital tract by some specific types of human papillomavirus (HPV).

Invasive Haemophilus influenzae disease

Haemophilus influenzae type b (Hib) is an obligate human pathogen and an important cause of invasive bacterial infections in both children and adults, with the highest incidence among young children.

Invasive pneumococcal disease

Despite good access to effective antibiotics, Streptococcus pneumoniae (pneumococci) is still a major cause of disease and death in both developing and developed countries.

Japanese encephalitis

The Japanese encephalitis virus is present in Asia, from Japan to India and Pakistan, and outbreaks are erratic and spatially and temporally limited phenomena, occurring quite unpredictably, even if all conditions appear to be present in a definite place. It is a leading cause of viral encephalitis in Asia, with 30-50,000 cases reported annually. Most human infections are asymptomatic. On average, one person in 200 infected develops a severe neuroinvasive illness. The case fatality rate in patients with severe disease is 20- 30% 

Measles

Measles is an acute, highly contagious viral disease capable of causing epidemics. Infectivity is close to 100% in susceptible individuals and in the pre-vaccine era measles would affect nearly every individual during childhood.

Meningococcal disease

Meningococcal disease is caused by Neisseria meningitidis, a bacterium with human carriers as the only reservoir. It is carried in the nose, where it can remain for long periods without producing symptoms.

Mumps

Mumps is an acute illness caused by the mumps virus. It is characterised by fever and swelling of one or more salivary glands (mumps is the only cause of epidemic infectious parotitis).

Pertussis

Pertussis, also known as whooping cough, is a highly contagious acute respiratory infection, caused by the bacterium Bordetella pertussis. The disease is characterised by a severe cough, which can last two months or even longer.

Poliomyelitis

Poliomyelitis, also known as polio or infantile paralysis, is a vaccine-preventable systemic viral infection affecting the motor neurons of the central nervous system (CNS). Historically, it has been a major cause of mortality, acute paralysis and lifelong disabilities but large scale immunisation programmes have eliminated polio from most areas of the world.

Rabies

Rabies is a disease caused by rabies virus (a Lyssavirus). Every year, a small number of cases of rabies is reported in Europe - travel-related or autochthonous.

Rotavirus infection

Rotavirus infection is an acute infectious disease mainly affecting children. The main symptoms are fever, vomiting and diarrhoea and many affected children suffer from extensive fluid loss in need of medical attention. The incubation period is 1-2 days.

Rubella

Rubella is a mild febrile rash illness caused by rubella virus. It is transmitted from person to person via droplets (the virus is present in throat secretions). It affects mainly, but not only, children and when pregnant women are infected, it may result in malformation of the foetus. Humans are the only reservoir of infection.

Seasonal influenza

Seasonal influenza is a preventable infectious disease with mostly respiratory symptoms. It is caused by influenza virus and is easily transmitted, predominantly via the droplet and contact routes and by indirect spread from respiratory secretions on hands etc.

Smallpox

Smallpox was a systemic disease, officially eradicated since 1979 (WHO), caused by infection with the Variola major virus, whose only reservoir was infected humans.

Tetanus

Tetanus is an often fatal disease, which is present worldwide. It is a consequence of a toxin produced by the bacterium Clostridium tetani. The main reservoirs of the bacterium are herbivores, which harbour the bacteria in their bowels (with no consequences for them) and disseminate the “spore form” of the bacteria in the environment with their faeces.

Tuberculosis

Tuberculosis (TB) is a serious infectious disease that can be fatal. It most commonly affects the lungs.

Typhoid and Paratyphoid Fever

Typhoid and paratyphoid fevers are systemic diseases caused by the bacteria Salmonella typhi and Salmonella paratyphi, respectively.

Varicella

Varicella (chickenpox) is caused by the varicella-zoster virus (VZV), which also causes shingles. The virus spreads through the body into the skin causing rashes to appear.

Yellow fever

Yellow fever (YF) cause a wide spectrum of symptoms, from mild to fatal. In severe cases there may be spontaneous haemorrhage. Mortality of these clinical cases can be as high as 80%, on a par with Ebola, Marburg and other haemorrhagic viral infections.